(Q33693343)

English

A phase III randomized, placebo-controlled study of topical amitriptyline and ketamine for chemotherapy-induced peripheral neuropathy (CIPN): a University of Rochester CCOP study of 462 cancer survivors

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

28 July 2017

A phase III randomized, placebo-controlled study of topical amitriptyline and ketamine for chemotherapy-induced peripheral neuropathy (CIPN): a University of Rochester CCOP study of 462 cancer survivors (English)

1 reference

Europe PubMed Central

PubMed publication ID

28 July 2017

0 references

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

peripheral neuropathy

1 reference

based on heuristic

inferred from title

Chemotherapy-induced peripheral neuropathy

1 reference

based on heuristic

inferred from title

author name string

Jennifer S Gewandter

1

1 reference

Europe PubMed Central

PubMed publication ID

28 July 2017

Supriya G Mohile

2

1 reference

Europe PubMed Central

PubMed publication ID

28 July 2017

Charles E Heckler

3

1 reference

Europe PubMed Central

PubMed publication ID

28 July 2017

Julie L Ryan

4

1 reference

Europe PubMed Central

PubMed publication ID

28 July 2017

Jeffrey J Kirshner

5

1 reference

Europe PubMed Central

PubMed publication ID

28 July 2017

Patrick J Flynn

6

1 reference

Europe PubMed Central

PubMed publication ID

28 July 2017

Judith O Hopkins

7

1 reference

Europe PubMed Central

PubMed publication ID

28 July 2017

Gary R Morrow

8

1 reference

Europe PubMed Central

PubMed publication ID

28 July 2017

publication date

16 February 2014

1 reference

Europe PubMed Central

PubMed publication ID

28 July 2017

Supportive Care in Cancer

1 reference

Europe PubMed Central

PubMed publication ID

28 July 2017

22

1 reference

Europe PubMed Central

PubMed publication ID

28 July 2017

7

1 reference

Europe PubMed Central

PubMed publication ID

28 July 2017

1807-1814

1 reference

Europe PubMed Central

PubMed publication ID

28 July 2017

Randomized double-blind placebo-controlled trial of acetyl-L-carnitine for the prevention of taxane-induced neuropathy in women undergoing adjuvant breast cancer therapy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4040331

14 July 2018

Effect of duloxetine on pain, function, and quality of life among patients with chemotherapy-induced painful peripheral neuropathy: a randomized clinical trial

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4040331

14 July 2018

Considerations for improving assay sensitivity in chronic pain clinical trials: IMMPACT recommendations

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4040331

14 July 2018

Efficacy of venlafaxine for the prevention and relief of oxaliplatin-induced acute neurotoxicity: results of EFFOX, a randomized, double-blind, placebo-controlled phase III trial.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4040331

14 July 2018

Topical preparations for pain relief: efficacy and patient adherence

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4040331

14 July 2018

Intravenous calcium and magnesium for oxaliplatin-induced sensory neurotoxicity in adjuvant colon cancer: NCCTG N04C7.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4040331

14 July 2018

A double-blind, placebo-controlled trial of a topical treatment for chemotherapy-induced peripheral neuropathy: NCCTG trial N06CA.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4040331

14 July 2018

Nortriptyline and gabapentin, alone and in combination for neuropathic pain: a double-blind, randomised controlled crossover trial

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4040331

14 July 2018

Chemotherapy-induced neuropathy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4040331

14 July 2018

Peripheral nerve damage associated with administration of taxanes in patients with cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4040331

14 July 2018

Prolonged-release oxycodone enhances the effects of existing gabapentin therapy in painful diabetic neuropathy patients

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4040331

14 July 2018

Amitriptyline in the treatment of chemotherapy-induced neuropathic symptoms

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4040331

14 July 2018

Efficacy of gabapentin in the management of chemotherapy-induced peripheral neuropathy: a phase 3 randomized, double-blind, placebo-controlled, crossover trial (N00C3).

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4040331

14 July 2018

Clinical approach to patients with neuropathic pain.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4040331

14 July 2018

Clinical activity of venlafaxine and topiramate against oxaliplatin-induced disabling permanent neuropathy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4040331

14 July 2018

Morphine, gabapentin, or their combination for neuropathic pain.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4040331

14 July 2018

Chemotherapy-induced peripheral neuropathy: pathogenesis and emerging therapies

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4040331

14 July 2018

A pilot study examining topical amitriptyline, ketamine, and a combination of both in the treatment of neuropathic pain

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4040331

14 July 2018

Phase III evaluation of nortriptyline for alleviation of symptoms of cis-platinum-induced peripheral neuropathy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4040331

14 July 2018

Topical application of doxepin hydrochloride, capsaicin and a combination of both produces analgesia in chronic human neuropathic pain: a randomized, double-blind, placebo-controlled study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4040331

14 July 2018

Pharmacological profile of antidepressants and related compounds at human monoamine transporters

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4040331

14 July 2018

Inhibition of neuronal Na+ channels by antidepressant drugs

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4040331

14 July 2018

Ketamine blocks an NMDA receptor-mediated component of synaptic transmission in rat hippocampus in a voltage-dependent manner.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4040331

14 July 2018

Burden of chemotherapy-induced neuropathy--a cross-sectional study.

1 reference

https://api.crossref.org/works/10.1007%2FS00520-014-2158-7

21 January 2018

Topical amitriptyline and ketamine in neuropathic pain syndromes: an open-label study

1 reference

https://api.crossref.org/works/10.1007%2FS00520-014-2158-7

21 January 2018

The interaction of ketamine with the opiate receptor

1 reference

https://api.crossref.org/works/10.1007%2FS00520-014-2158-7

21 January 2018

Assessing symptom distress in cancer patients: the M.D. Anderson Symptom Inventory.

1 reference

https://api.crossref.org/works/10.1007%2FS00520-014-2158-7

21 January 2018

Pregabalin for the treatment of postherpetic neuralgia: a randomized, placebo-controlled trial

1 reference

https://api.crossref.org/works/10.1007%2FS00520-014-2158-7

21 January 2018

Prevention of oxaliplatin-related neurotoxicity by calcium and magnesium infusions: a retrospective study of 161 patients receiving oxaliplatin combined with 5-Fluorouracil and leucovorin for advanced colorectal cancer

1 reference

https://api.crossref.org/works/10.1007%2FS00520-014-2158-7

21 January 2018

Glutathione reduces the toxicity and improves quality of life of women diagnosed with ovarian cancer treated with cisplatin: results of a double-blind, randomised trial.

1 reference

https://api.crossref.org/works/10.1007%2FS00520-014-2158-7

21 January 2018

Administration of reduced glutathione in FOLFOX4 adjuvant treatment for colorectal cancer: effect on oxaliplatin pharmacokinetics, Pt-DNA adduct formation, and neurotoxicity

1 reference

https://api.crossref.org/works/10.1007%2FS00520-014-2158-7

21 January 2018

Amelioration of docetaxel/cisplatin induced polyneuropathy by alpha-lipoic acid

1 reference

https://api.crossref.org/works/10.1007%2FS00520-014-2158-7

21 January 2018

Effective treatment of oxaliplatin-induced cumulative polyneuropathy with alpha-lipoic acid

1 reference

https://api.crossref.org/works/10.1007%2FS00520-014-2158-7

21 January 2018

Efficacy of lamotrigine in the management of chemotherapy-induced peripheral neuropathy: a phase 3 randomized, double-blind, placebo-controlled trial, N01C3.

1 reference

https://api.crossref.org/works/10.1007%2FS00520-014-2158-7

21 January 2018

Role of pregabalin in treatment of oxaliplatin-induced sensory neuropathy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4040331

30 October 2018

Amitriptyline in the prevention of chemotherapy-induced neuropathic symptoms.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4040331

30 October 2018

A pilot study on the effect of acetyl-L-carnitine in paclitaxel- and cisplatin-induced peripheral neuropathy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4040331

30 October 2018

Weekly cisplatin +- glutathione in relapsed ovarian carcinoma

1 reference

https://api.crossref.org/works/10.1007%2FS00520-014-2158-7

21 January 2018

Chemotherapy-induced peripheral neuropathy

1 reference

https://pubmed.ncbi.nlm.nih.gov/24531792

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1007/S00520-014-2158-7

1 reference

Europe PubMed Central

PubMed publication ID

28 July 2017

PMC publication ID

1 reference

Europe PubMed Central

PubMed publication ID

28 July 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

28 July 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q33693343&oldid=2195655357"